BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21901315)

  • 1. Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle.
    Afzal F; Qvigstad E; Aronsen JM; Moltzau LR; Sjaastad I; Skomedal T; Osnes JB; Levy FO
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Dec; 384(6):543-53. PubMed ID: 21901315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT4-elicited positive inotropic response is mediated by cAMP and regulated by PDE3 in failing rat and human cardiac ventricles.
    Afzal F; Andressen KW; Mørk HK; Aronsen JM; Sjaastad I; Dahl CP; Skomedal T; Levy FO; Osnes JB; Qvigstad E
    Br J Pharmacol; 2008 Dec; 155(7):1005-14. PubMed ID: 18846035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts.
    Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR
    Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the regulation of the inotropic response to 5-HT4 receptor activation via phosphodiesterases and its cross-talk with C-type natriuretic peptide in porcine left atrium.
    Weninger S; De Maeyer JH; Lefebvre RA
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):565-77. PubMed ID: 22426996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
    Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
    Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensors.
    Manfra O; Calamera G; Froese A; Arunthavarajah D; Surdo NC; Meier S; Melleby AO; Aasrum M; Aronsen JM; Nikolaev VO; Zaccolo M; Moltzau LR; Levy FO; Andressen KW
    Cardiovasc Res; 2022 May; 118(6):1506-1519. PubMed ID: 33970224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
    Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW
    Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic AMP-dependent inotropic effects are differentially regulated by muscarinic G(i)-dependent constitutive inhibition of adenylyl cyclase in failing rat ventricle.
    Hussain RI; Afzal F; Mørk HK; Aronsen JM; Sjaastad I; Osnes JB; Skomedal T; Levy FO; Krobert KA
    Br J Pharmacol; 2011 Feb; 162(4):908-16. PubMed ID: 21039419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of β2 -adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricle.
    Afzal F; Aronsen JM; Moltzau LR; Sjaastad I; Levy FO; Skomedal T; Osnes JB; Qvigstad E
    Br J Pharmacol; 2011 Jan; 162(1):54-71. PubMed ID: 21133887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium.
    Moltzau LR; Meier S; Aronsen JM; Afzal F; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):407-17. PubMed ID: 24424715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice.
    Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M
    Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
    Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
    J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of phosphodiesterases and cGMP on cAMP generation and on phosphorylation of phospholamban and troponin I by 5-HT4 receptor activation in porcine left atrium.
    Weninger S; De Maeyer JH; Lefebvre RA
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):671-84. PubMed ID: 23549671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 facilitates inotropic effects of 5-HT4 serotonin receptors and β-adrenoceptors in failing human heart.
    Riise J; Ørstavik Ø; Qvigstad E; Dahl CP; Osnes JB; Skomedal T; Levy FO; Krobert KA
    Basic Res Cardiol; 2012 Sep; 107(5):295. PubMed ID: 22923058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
    Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
    Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes.
    Birkeland JA; Swift F; Tovsrud N; Enger U; Lunde PK; Qvigstad E; Levy FO; Sejersted OM; Sjaastad I
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2367-76. PubMed ID: 17660386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices.
    Zielińska M; Fresko I; Konopacka A; Felipo V; Albrecht J
    Neurotoxicology; 2007 Nov; 28(6):1260-3. PubMed ID: 17629948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.
    Molenaar P; Christ T; Hussain RI; Engel A; Berk E; Gillette KT; Chen L; Galindo-Tovar A; Krobert KA; Ravens U; Levy FO; Kaumann AJ
    Br J Pharmacol; 2013 Jun; 169(3):528-38. PubMed ID: 23489141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure.
    Qvigstad E; Brattelid T; Sjaastad I; Andressen KW; Krobert KA; Birkeland JA; Sejersted OM; Kaumann AJ; Skomedal T; Osnes JB; Levy FO
    Cardiovasc Res; 2005 Mar; 65(4):869-78. PubMed ID: 15721867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle.
    Moltzau LR; Aronsen JM; Meier S; Skogestad J; Ørstavik Ø; Lothe GB; Sjaastad I; Skomedal T; Osnes JB; Levy FO; Qvigstad E
    J Pharmacol Exp Ther; 2014 Sep; 350(3):681-90. PubMed ID: 25022512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.